These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 11817973)

  • 21. Significance of endothelial prostacyclin and nitric oxide in peripheral and pulmonary circulation.
    Gryglewski RJ; Chłopicki S; Uracz W; Marcinkiewicz E
    Med Sci Monit; 2001; 7(1):1-16. PubMed ID: 11208485
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of nebivolol versus other antihypertensive drugs on the endothelial dysfunction in patients with essential hypertension.
    Li B; Zhang Q; Zhang H; Wang C; Xiu R
    Biosci Rep; 2020 May; 40(5):. PubMed ID: 32342981
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Calcium antagonist treatment by lercanidipine prevents hyperpolarization in essential hypertension.
    Taddei S; Virdis A; Ghiadoni L; Versari D; Salvetti G; Magagna A; Salvetti A
    Hypertension; 2003 Apr; 41(4):950-5. PubMed ID: 12642509
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Endothelium-dependent contractions and endothelial dysfunction in human hypertension.
    Versari D; Daghini E; Virdis A; Ghiadoni L; Taddei S
    Br J Pharmacol; 2009 Jun; 157(4):527-36. PubMed ID: 19630832
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of nebivolol on blood oxygen transport indices and endothelial dysfunction in patients with arterial hypertension.
    Pronko TP; Zinchuk VV
    Clin Physiol Funct Imaging; 2009 May; 29(3):170-6. PubMed ID: 19170724
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nebivolol: a highly selective beta1-adrenergic receptor blocker that causes vasodilation by increasing nitric oxide.
    Gupta S; Wright HM
    Cardiovasc Ther; 2008; 26(3):189-202. PubMed ID: 18786089
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of barnidipine in comparison with hydrochlorothiazide on endothelial function, as assessed by flow mediated vasodilatation in hypertensive patients.
    Muiesan ML; Salvetti M; Belotti E; Paini A; Rosei CA; Aggiusti C; Scotti A; de Ciuceis C; Rizzoni D; Rosei EA
    Blood Press; 2011 Aug; 20(4):244-51. PubMed ID: 21332412
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Endothelial function as an end-point in interventional trials: concepts, methods and current data.
    Lüscher TF; Noll G
    J Hypertens Suppl; 1996 Sep; 14(2):S111-9; discussion S119-21. PubMed ID: 8934387
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lacidipine improves endothelial repair capacity of endothelial progenitor cells from patients with essential hypertension.
    Liu X; Zhang GX; Zhang XY; Xia WH; Yang Z; Su C; Qiu YX; Xu SY; Zhan H; Tao J
    Int J Cardiol; 2013 Oct; 168(4):3317-26. PubMed ID: 23642821
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chronic treatment with long-acting nifedipine reduces vasoconstriction to endothelin-1 in essential hypertension.
    Sudano I; Virdis A; Taddei S; Spieker L; Corti R; Noll G; Salvetti A; Luscher TF
    Hypertension; 2007 Feb; 49(2):285-90. PubMed ID: 17178974
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nebivolol treatment reduces serum levels of asymmetric dimethylarginine and improves endothelial dysfunction in essential hypertensive patients.
    Pasini AF; Garbin U; Stranieri C; Boccioletti V; Mozzini C; Manfro S; Pasini A; Cominacini M; Cominacini L
    Am J Hypertens; 2008 Nov; 21(11):1251-7. PubMed ID: 18772860
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endothelial function in hypertension.
    Mattei P; Virdis A; Ghiadoni L; Taddei S; Salvetti A
    J Nephrol; 1997; 10(4):192-7. PubMed ID: 9377726
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Angiotensin II type I receptor blocker and endothelial function in humans: role of nitric oxide and oxidative stress.
    Higashi Y; Chayama K; Yoshizumi M
    Curr Med Chem Cardiovasc Hematol Agents; 2005 Apr; 3(2):133-48. PubMed ID: 15853700
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impairment and restoration of nitric oxide-dependent vasodilation in cardiovascular disease.
    Lyons D
    Int J Cardiol; 1997 Dec; 62 Suppl 2():S101-9. PubMed ID: 9488201
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Endothelial dysfunction in human essential hypertension.
    Mordi I; Mordi N; Delles C; Tzemos N
    J Hypertens; 2016 Aug; 34(8):1464-72. PubMed ID: 27203578
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical significance of the assessment of endothelial function].
    Taddei S; Ghiadoni L; Virdis A; Versari D; Salvetti A
    Ital Heart J Suppl; 2004 May; 5(5):357-65. PubMed ID: 15182062
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endothelial dysfunction and cardiovascular risk factors.
    Grover-Páez F; Zavalza-Gómez AB
    Diabetes Res Clin Pract; 2009 Apr; 84(1):1-10. PubMed ID: 19185380
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Endothelial dysfunction in human disease.
    Drexler H; Hornig B
    J Mol Cell Cardiol; 1999 Jan; 31(1):51-60. PubMed ID: 10072715
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of treatment strategy on endothelial function.
    Tomasoni L; Sitia S; Borghi C; Cicero AF; Ceconi C; Cecaro F; Morganti A; De Gennaro Colonna V; Guazzi M; Morricone L; Malavazos AE; Marino P; Cavallino C; Shoenfeld Y; Turiel M
    Autoimmun Rev; 2010 Oct; 9(12):840-4. PubMed ID: 20678593
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of losartan, compared with atenolol, on endothelial function and oxidative stress in patients with type 2 diabetes and hypertension.
    Flammer AJ; Hermann F; Wiesli P; Schwegler B; Chenevard R; Hürlimann D; Sudano I; Gay S; Neidhart M; Riesen W; Ruschitzka F; Lüscher TF; Noll G; Lehmann R
    J Hypertens; 2007 Apr; 25(4):785-91. PubMed ID: 17351370
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.